Prognosis and survival for biliary tract cancers

Last medical review:

A prognosis is the doctor's best estimate of how cancer will affect you and how it will respond to treatment. Survival is the percentage of people with a disease who are alive at some point in time after their diagnosis. Prognosis and survival depend on many factors.

The doctor will look at characteristics of the person and certain aspects of the cancer, such as its stage and grade and where in the biliary tract the cancer started. These are called prognostic factors. The doctor will also look at predictive factors, which influence how a cancer will respond to a certain treatment and how likely it is that the cancer will come back after treatment.

Prognostic and predictive factors are often discussed together. They both play a part in deciding on a prognosis and a treatment plan just for you. Only a doctor familiar with your medical history, the type, stage and other features of the cancer, the treatments chosen and the response to treatment can put all of this information together with survival statistics to arrive at a prognosis and chances of survival.

The following are prognostic and predictive factors for biliary tract cancers.

Resectability

Surgery is the most effective treatment for biliary tract cancers. This means that the most important prognostic factor for biliary tract cancers is whether a tumour can be removed completely through with surgery (called resectability). Tumours that can be completely removed with surgery (resectable) have a much more favourable prognosis than tumours that cannot be removed by surgery (unresectable). Early-stage cancers, smaller tumours, or those that have not spread to other organs or tissues are most likely to be resectable.

Stage

The stage describes how much cancer is in the body, where it is and how far it has spread. Biliary tract cancers start in the cells of the gallbladder (primary gallbladder cancer) or bile duct (primary bile duct cancer), but can grow into nearby tissue and destroy it. It can also spread (metastasize) to other parts of the body.

People with early-stage biliary tract cancers have a better prognosis than those with advanced biliary tract cancers. Tumours that are still in the innermost layer of the gallbladder or bile duct (the mucosa) have the most favourable prognosis. Tumours that have spread through the gallbladder or bile duct walls and into nearby lymph nodes or organs have a worse prognosis.

Metastasis

Tumours that are still localized to the gallbladder or bile duct have the most favourable prognosis. Prognosis is poor when tumours have spread to distant organs or into lymph nodes or blood vessels (called lymphovascular invasion) .

Grade

Gallbladder tumours that are more differentiated and slow growing (low-grade) have a better prognosis than tumours that are fast-growing (high-grade).

Location of the tumour

Tumours that are located farther fom the liver typically have a better prognosis. Tumours in the distal part of the bile ducts usually have a better prognosis than intrahepatic or perihilar cholangiocarcinoma.

Type of tumour

Papillary gallbladder adenocarcinoma usually has a better prognosis than other biliary tract cancers.

Expert review and references

  • Jamil Asselah, MD
  • Beaulieu C, Lui A, Yusuf D, Abdelaziz Z, Randolph B, Batuyong E, et al.. A population-based retrospective study of biliary tract cancers in Alberta, Canada. Current Oncology. 2021: 28(1):417–427.
  • Feroz Z, Gautam P, Tiwan S, Shukla G, Kumar M. Survival analysis and prognostic factors of the carcinoma of the gallbladder. World Journal of Surgical Oncology. 2022: 20:403.
  • Goetze TO. Gallbladder carcinoma: prognostic factors and therapeutic options. World Journal of Gastroenterology. 2015: 21(43):12211–12217.
  • Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clinical Epidemiology. 2014: 6:99–109.
  • Kang MJ, Lim J, Han SS, Park HM, Kim SW, Lee WJ, et al.. Distinct prognosis of biliary tract cancer according to tumor location, stage, and treatment: a population-based study. Scientific Reports. 2022: 12:10206.
  • Kwon HJ, Kim SG, Chun JM, Lee WK, Hwang YJ. Prognostic factors in patients with middle and distal bile duct cancers. World Journal of Gastroenterology. 2014: 20(21):6658–6665.
  • Lui AGA, Yusuf D, Randolph B, Tam VC, Bathe OF, Ghosh S, et al.. A population-based study of biliary tract cancers (BTCs) in Alberta, Canada: How do our patients fare?. Journal of Clinical Oncology. 2017: 35(4 Supplemental):246.
  • Rawla P, Sunkara T, Thandra KC, Barsouk A. Epidemiology of gallbladder cancer. Clinical and Experimental Hepatology. 2019: 5(2):93–102.

Survival statistics for biliary tract cancers

Survival statistics for gallbladder and bile duct cancer are very general estimates. Survival is different for each stage and type of tumour.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2024 Canadian Cancer Society